cyclandelate has been researched along with Cerebrovascular Disorders in 11 studies
Cyclandelate: A direct-acting SMOOTH MUSCLE relaxant used to dilate BLOOD VESSELS.
cyclandelate : The ester obtained by formal condensation of mandelic acid and 3,3,5-tricyclohexanol. It is a direct-acting smooth muscle relaxant used to dilate blood vessels.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A double-blind, double-dummy clinical trial was conducted in which the efficacy of cyclandelate 1600 mg daily was compared with that of flunarizine 10mg daily in 40 patients (25 men and 15 women) with dementia of cerebrovascular origin." | 9.06 | Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementia. ( Albizzati, MG; Bassi, S; Calloni, E; Frattola, L; Piolti, R; Sbacchi, M, 1987) |
| "A multicentre study with 622 patients has been undertaken to evaluate the efficacy of cyclandelate 1600 mg daily in the treatment of vertigo of circulatory origin in general practice." | 7.67 | Cyclandelate in the treatment of vertigo of circulatory origin. A study in general practice. ( de Halleux, F, 1987) |
| "A double-blind, double-dummy clinical trial was conducted in which the efficacy of cyclandelate 1600 mg daily was compared with that of flunarizine 10mg daily in 40 patients (25 men and 15 women) with dementia of cerebrovascular origin." | 5.06 | Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementia. ( Albizzati, MG; Bassi, S; Calloni, E; Frattola, L; Piolti, R; Sbacchi, M, 1987) |
| "A multicentre study with 622 patients has been undertaken to evaluate the efficacy of cyclandelate 1600 mg daily in the treatment of vertigo of circulatory origin in general practice." | 3.67 | Cyclandelate in the treatment of vertigo of circulatory origin. A study in general practice. ( de Halleux, F, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blakemore, CB | 2 |
| Albizzati, MG | 3 |
| Bassi, S | 3 |
| Sbacchi, M | 3 |
| Frattola, L | 3 |
| Foltyn, P | 1 |
| Lücker, PW | 1 |
| Schnitker, J | 1 |
| Cook, P | 1 |
| James, I | 1 |
| Offerhaus, L | 1 |
| Buscaino, GA | 1 |
| Sourander, L | 1 |
| Calloni, E | 1 |
| Piolti, R | 1 |
| Memin, Y | 1 |
| de Halleux, F | 1 |
2 reviews available for cyclandelate and Cerebrovascular Disorders
| Article | Year |
|---|---|
The clinical efficacy of Cyclospasmol: a review of the literature.
Topics: Aged; Cerebrovascular Disorders; Cyclandelate; Dementia; Humans; Mandelic Acids; Vascular Diseases | 1984 |
Drug therapy: cerebral vasodilators (first of two parts).
Topics: Aged; Aging; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cycla | 1981 |
5 trials available for cyclandelate and Cerebrovascular Disorders
| Article | Year |
|---|---|
Clinical effects of Cyclospasmol in patients affected by chronic cerebrovascular disorders.
Topics: Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Cyclandelate; Female; Humans; Male; Mande | 1984 |
[Efficacy of an etofylline-cyclandelate combination in age-dependent cerebrovascular insufficiency].
Topics: Aged; Cerebrovascular Disorders; Cyclandelate; Drug Combinations; Female; Humans; Male; Mandelic Aci | 1982 |
Drug therapy: cerebral vasodilators (first of two parts).
Topics: Aged; Aging; Cerebrovascular Circulation; Cerebrovascular Disorders; Clinical Trials as Topic; Cycla | 1981 |
Effects of Cyclospasmol upon sensory parameters in patients recovering from cerebrovascular accidents.
Topics: Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Cyclandelate; Dose-Response Relationship, | 1978 |
Cyclandelate versus flunarizine. A double-blind study in a selected group of patients with dementia.
Topics: Aged; Cerebrovascular Disorders; Clinical Trials as Topic; Cyclandelate; Dementia; Double-Blind Meth | 1987 |
5 other studies available for cyclandelate and Cerebrovascular Disorders
| Article | Year |
|---|---|
Chronic cerebrovascular disorders: a clinical study with cyclandelate.
Topics: Aged; Cerebrovascular Disorders; Chronic Disease; Cyclandelate; Female; Humans; Male; Mandelic Acids | 1984 |
[Indications for and effects of vasodilating agents, especially in cerebral and peripheral vascular sclerosis].
Topics: Aged; Arterial Occlusive Diseases; Cerebrovascular Disorders; Cyclandelate; Dihydroergotoxine; Femal | 1981 |
[Medical treatment of acute disorders of cerebral circulation].
Topics: Aminophylline; Anticoagulants; Antihypertensive Agents; Brain Edema; Cerebrovascular Disorders; Cinn | 1980 |
Perceived efficacy of cyclandelate in the treatment of cochleovestibular and retinal disturbances related to cerebrovascular insufficiency. A study in general practice comprising 2772 patients.
Topics: Adult; Aged; Cerebrovascular Disorders; Cochlea; Cyclandelate; Female; Humans; Labyrinth Diseases; M | 1987 |
Cyclandelate in the treatment of vertigo of circulatory origin. A study in general practice.
Topics: Aged; Aged, 80 and over; Aging; Cerebrovascular Disorders; Cyclandelate; Female; Humans; Male; Mande | 1987 |